Optimising team functioning, preventing relapse and enhancing recovery in Crisis Resolution Teams (CRTs): the CORE Programme (Crisis team Optimisation and RElapse prevention) CORE Phase 4: A Cluster Randomised Controlled Trial: Evaluation of implementation of a CRT Resource Kit

Phase 4

Completed

• Conditions: Topic: Mental Health; Subtopic: Psychosis; Disease: Psychosis; Mental and Behavioural Disorders

• Registration Number: ISRCTN47185233
• Lead Sponsor: Camden and Islington NHS Foundation Trust (UK)

Brief Summary

2015 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/27004517 2019 results in: http://www.ncbi.nlm.nih.gov/pubmed/30986008 [added 16/04/2019]

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-08-14
• Study Completion: 2017-04-30
• Last Update Posted: 5 May 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1265

Inclusion Criteria

Service user inclusion criteria:
Adults (aged 18+) who have been on the caseload of a participating Crisis Resolution Team for at least a week

CRT inclusion criteria:
UK CRT

Target Gender: Male & Female; Lower Age Limit 18 years

Exclusion Criteria

Service user exclusion criteria:
1. People who lack capacity to consent to take part in the study
2. People who in the view of the clinical team at their Crisis Resolution Team present such a high risk of harm to others, it would be unsafe for researchers to contact them about participation, even just by phone or email.
3. People who are discharged to addresses outside the catchment area.
4. People who cannot understand the study information sheet or questionnaire when delivered in English.

CRT exclusion criteria:
1. CRT teams identified in a previous national survey conducted at an earlier stage of the CORE study as already operating at high fidelity (mean item score above 4) - i.e. teams with comparatively little capacity for service improvement
2. CRT teams where major change to the organisation of the service is planned during the duration of the trial
3. CRTs taking part in the concurrent CORE Phase 3 trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified